Open-Label, Flexible-dose Study to Evaluate the Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia or Bipolar I Disorder
Conditions: Schizophrenia; Bipolar I Disorder Intervention: Drug: Cariprazine Flexible Dose Sponsor: Allergan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials